ArticleBMC endocrine disorders2026
Sleep duration and prevalent osteoporosis among U.S. postmenopausal women: a cross-sectional analysis of NHANES 2007-2018 with assessment of potential effect modification by physical activity.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveAbnormal sleep duration may be associated with osteoporosis. This study aimed to evaluate the nonlinear association between sleep duration and osteoporosis prevalence in postmenopausal women and to further examine whether this association differed according to physical activity (PA) status.
methodsThis cross-sectional study included 4,775 postmenopausal women from the National Health and Nutrition Examination Survey (NHANES) 2007-2018. Using the NHANES complex survey design and examination weights, we applied survey-weighted multivariable logistic regression models to examine the association between sleep duration and osteoporosis. Restricted cubic spline (RCS) analyses were performed to evaluate potential nonlinear associations and threshold effects. PA-stratified analyses, interaction tests, and joint association analyses were further performed. Multiple sensitivity analyses were performed to assess the robustness of the findings.
resultsIn the fully adjusted model, both short sleep duration (OR = 1.64, 95% CI: 1.26-2.14, P < 0.001) and long sleep duration (OR = 2.90, 95% CI: 1.55-5.43, P = 0.001) were associated with higher odds of prevalent osteoporosis compared with moderate sleep duration. RCS analyses indicated a U-shaped association between sleep duration and prevalent osteoporosis (P for overall = 0.0002; P for nonlinearity = 0.0003), with the lowest estimated odds at approximately 7.16 h/night. High PA was independently associated with lower odds of prevalent osteoporosis. PA may modify the association between sleep duration and prevalent osteoporosis (P for interaction = 0.010). In PA-stratified analyses, among women with high PA, the ORs for prevalent osteoporosis were 2.02 (95% CI: 1.36-2.99) for short sleep and 6.60 (95% CI: 3.03-14.38) for long sleep, compared with moderate sleep duration. The corresponding ORs among women with low PA were 1.38 (95% CI: 0.95-2.01) and 1.68 (95% CI: 0.88-3.21), respectively. Joint analyses indicated that women with both high PA and moderate sleep duration had the lowest odds of prevalent osteoporosis.
conclusionAmong postmenopausal women in the United States (US), sleep duration was associated with osteoporosis prevalence in a U-shaped manner. Both short and long sleep duration were associated with higher odds of osteoporosis. PA may modify this association. Sleep duration and PA should be considered jointly in observational assessments of lifestyle factors associated with bone health. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.